Sympathetic Neural Overactivation, Vascular Dysfunction, and Exercise Intolerance in Long-Term Survivors of Breast Cancer Treated With Doxorubicin and Trastuzumab-Based Chemotherapy
Journal Article
Overview
publication date
- March 17, 2026
has subject area
- Adult
- Aminoglycosides - Doxorubicin
- Blood Proteins - Trastuzumab
- Breast Diseases - Breast Neoplasms
- Cancer Survivors
- Drug Therapy - Antineoplastic Combined Chemotherapy Protocols
- Drug Therapy, Combination - Antineoplastic Combined Chemotherapy Protocols
- Environment and Public Health - Case-Control Studies
- Exercise Tolerance
- Female
- Globulins - Trastuzumab
- Health Care Evaluation Mechanisms - Case-Control Studies
- Humans
- Hydrocarbons, Aromatic - Doxorubicin
- Immunoproteins - Trastuzumab
- Investigative Techniques - Case-Control Studies
- Middle Aged
- Neoplasms by Site - Breast Neoplasms
- Polycyclic Compounds - Doxorubicin
- Sympathetic Nervous System
- Therapeutics - Antineoplastic Combined Chemotherapy Protocols
Date in CU Experts
- March 22, 2026 12:41 PM
Full Author List
- Izaias JE; Sales AO; Ono BE; Rodrigues TS; Silva GMPS; Pentagna PS; Albuquerque ALP; Folchini FN; Colombo FMC; Irigoyen MCC
author count
- 29
citation count
- 1
published in
Other Profiles
Electronic International Standard Serial Number (EISSN)
- 2047-9980
Digital Object Identifier (DOI)
Additional Document Info
volume
- 15
issue
- 6
number
- ARTN e048047